FEDERAL STREET STRATEGIES, LLC for ABBVIE, INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Patient access to drug treatment therapies; and drug cost and drug pricing reform efforts. H.R. 3 - Lower Drug Costs Now Act of 2019 S.2543, Prescription Drug Pricing Reduction Act of 2019 Policies related to the treatment of Uterine Fibroids
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL BRATHWAITE | Executive Director, Congressional Black Caucus; Deputy Assistant Secretary, ESA, U.S. Department of Labor; Special Assistant to the Secretary, U.S. Department of Labor. |
| DERRON PARKS New | — |
Medicare/Medicaid MMM
Medicare Part D policies. H.R. 3 - Lower Drug Costs Now Act of 2019 S.2543, Prescription Drug Pricing Reduction Act of 2019
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL BRATHWAITE | Executive Director, Congressional Black Caucus; Deputy Assistant Secretary, ESA, U.S. Department of Labor; Special Assistant to the Secretary, U.S. Department of Labor. |
| DERRON PARKS New | — |
Medical/Disease Research/Clinical Labs MED
Transparency of prescription drug pricing; and patient costs of prescription drugs. H.R. 3 - Lower Drug Costs Now Act of 2019 S.2543, Prescription Drug Pricing Reduction Act of 2019
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL BRATHWAITE | Executive Director, Congressional Black Caucus; Deputy Assistant Secretary of Labor, ESA, U.S. Department of Labor; Special Assistant to the Secretary, U.S. Department of Labor. |
| DERRON PARKS New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.